Major Novartis shareholder calls for board shake-up after drug trial setbacks

A major shareholder in Novartis has called for a shake-up of the Swiss drugmaker's board to improve corporate governance after its shares suffered a record fall this week ​following back-to-back trial...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。